Bloomage BioTechnology's high P/E ratio could face pressure ...
Bloomage BioTechnology's high P/E ratio could face pressure due to weak earnings outlook and slower growth. Overly bullish investors refusing to sell at current prices may face future disappointment.
What Bloomage BioTechnology Corporation Limited's (SHSE:688363) P/E Is Not Telling You
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment